Page 19 - Assessing right ventricular function and the pulmonary circulation in pulmonary hypertension Onno Anthonius Spruijt
P. 19
References:
[1] Nossaman BD, Scruggs BA, Nossaman VE, Murthy SN, Kadowitz PJ. History of right heart catheterization: 100 years of experimentation and methodology development. Cardiology in review. 2010; 18:94-101
[2] Wood P. Pulmonary hypertension with special reference to the vasoconstrictive factor. British heart journal. 1958; 20:557-70
[3] Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The European respiratory journal. 2009; 34:1219-63
[4] Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle- pulmonary circulation unit: state of the art and clinical and research implications. Circulation. 2009; 120:992-1007
[5] Lankhaar JW, Westerhof N, Faes TJ, Gan CT, Marques KM, Boonstra A, et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. European heart journal. 2008; 29:1688-95
[6] Lankhaar JW, Westerhof N, Faes TJ, Marques KM, Marcus JT, Postmus PE, et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. American journal of physiology. 2006; 291:H1731-7
[7] Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation. 2012; 125:289-97
[8] Argiento P, Vanderpool RR, Mule M, Russo MG, D'Alto M, Bossone E, et al. Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. Chest. 2012; 142:1158-65
[9] Mehta PA, Dubrey SW. High output heart failure. Qjm. 2009; 102:235-41
[10] Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004; 363:1461-8
[11] Spruijt OA, Bogaard HJ, Vonk-Noordegraaf A. Pulmonary arterial hypertension combined with a high cardiac output state: Three remarkable cases. Pulmonary circulation. 2013; 3:440-3
[12] Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. Journal of the American College of Cardiology. 2013; 62:D22-33
[13] Rain S, Handoko ML, Trip P, Gan CT, Westerhof N, Stienen GJ, et al. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation. 2013; 128:2016-25, 1-10
[14] Trip P, Rain S, Handoko ML, van der Bruggen C, Bogaard HJ, Marcus JT, et al. Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension. The European respiratory journal. 2015; 45:1603-12
[15] Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010; 122:164-72
[16] Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010; 122:156-63
[17] van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, Bogaard HJ, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. Journal of the American College of Cardiology. 2011; 58:2511-9
[18] van de Veerdonk MC, Marcus JT, Westerhof N, de Man FS, Boonstra A, Heymans MW, et al. Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension. Chest. 2015; 147:1063-71
[19] van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. European heart journal. 2007; 28:1250-7
[20] Waxman AB. Exercise physiology and pulmonary arterial hypertension. Progress in cardiovascular diseases. 2012; 55:172-9
[21] Holverda S, Gan CT, Marcus JT, Postmus PE, Boonstra A, Vonk-Noordegraaf A. Impaired stroke volume response to exercise in pulmonary arterial hypertension. Journal of the American College of Cardiology. 2006; 47:1732-3
[22] Ramos RP, Arakaki JS, Barbosa P, Treptow E, Valois FM, Ferreira EV, et al. Heart rate recovery in pulmonary arterial hypertension: relationship with exercise capacity and prognosis. American heart journal. 2012; 163:580-8
[23] Fowler RM, Gain KR, Gabbay E. Exercise intolerance in pulmonary arterial hypertension. Pulmonary medicine. 2012; 2012:359204
[24] Claessen G, La Gerche A, Dymarkowski S, Claus P, Delcroix M, Heidbuchel H. Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy. Journal of the American Heart Association. 2015; 4:e001602
[25] Claessen G, La Gerche A, Wielandts JY, Bogaert J, Van Cleemput J, Wuyts W, et al. Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension. Heart (British Cardiac Society). 2015; 101:637-44
[26] Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004; 110:1308-12
[27] Provencher S, Chemla D, Herve P, Sitbon O, Humbert M, Simonneau G. Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension. The European respiratory journal. 2006; 27:114-20
[28] Minai OA, Gudavalli R, Mummadi S, Liu X, McCarthy K, Dweik RA. Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension. American journal of respiratory and critical care medicine. 2012; 185:400-8
Chapter 1
17
1